Vertex Pharma shares hit life high as cystic fibrosis data wows

(Reuters) - Shares of Vertex Pharmaceuticals Inc soared to touch a record high on Wednesday, a day after the drugmaker revealed data on its triple combinations of cystic fibrosis (CF) treatments that wowed both analysts and investors.